Alere Toxicology
Alere Toxicology (now Abbott Toxicology) is a drug and alcohol testing services provider offering rapid screening devices, laboratory urine and oral fluid testing, and online result reporting to workplace, government, and clinical customers worldwide.
- Company typePrivate
- Founded1987
- HeadquartersRichmond, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What Alere Toxicology does
Alere Toxicology is a drug and alcohol testing services business that operates as part of Abbott Laboratories following Abbott's 2017 acquisition of Alere Inc. for approximately $5.3 billion. The company is now branded as Abbott Toxicology, though the Learning XChange platform retains the legacy aleretoxicology.com domain. The firm provides a portfolio spanning rapid point-of-collection screening devices (notably the iCup urine drug screen cup), reagent and consumable products, and laboratory drug testing services covering both urine and oral fluid specimens. Multiple dedicated toxicology laboratory facilities worldwide support a global testing operation, with the company claiming more than 30 years of laboratory testing experience.
The business serves three primary customer segments: workplace screening (pre-employment, random, post-accident, return-to-duty, and occupational health testing for employers), government (federal, state, and local agencies including law enforcement, probation, and military testing programs requiring chain-of-custody compliance), and clinical toxicology (healthcare providers requiring diagnostic testing). Revenue is generated through a mix of fee-for-service laboratory testing, hardware and consumables sales for screening devices, and professional services revenue from the Learning XChange training and certification platform. Distribution is handled through a global direct enterprise sales force for large workplace and government accounts, supplemented by online product catalogs and ordering portals (WEBORDERS, drugtestsupplies.com) for mid-market customers. Pricing is quote-based and not publicly disclosed, consistent with regulated enterprise and government procurement.
Strategic positioning rests on regulatory compliance, certified laboratory operations (with publicly listed laboratory certifications), HIPAA-compliant patient information handling, and integration into Abbott's broader diagnostics ecosystem, including the Global Point of Care franchise. Competitive advantages cited by the company include brand recognition under the Abbott umbrella, proprietary rapid screening technology, and the scale of its multi-facility laboratory network. The unit does not publish standalone financial results, and its performance is consolidated within Abbott's diagnostics segment.
Alere Toxicology firmographics
Firmographics- Name
- Alere Toxicology
- Legal name
- Alere Toxicology
- Website
- https://aleretoxicology.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Alere Toxicology (now Abbott Toxicology) is a drug and alcohol testing services provider offering rapid screening devices, laboratory urine and oral fluid testing, and online result reporting to workplace, government, and clinical customers worldwide.
- Ownership category
- akta.pro rank
Alere Toxicology industry classification
Industry- Product category
- Drug and Alcohol Testing Services
- NAICS
- Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)
Keywords
Where Alere Toxicology is headquartered
LocationHeadquarters
- HQ city
- Richmond
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Alere Toxicology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Laboratory Testing Services: Fee-for-service laboratory drug testing including urine and oral fluid testing. Services provided to workplace, government, and clinical customers requiring compliant specimen analysis
- Rapid Screening Products: Sale of rapid drug screening devices (cups, reagents) for point-of-collection testing. Products sold directly to customers and through distribution
- Reagents and Consumables: Ongoing reagent supplies and consumables for drug testing equipment
- Training Services: Online training programs via Learning Xchange platform with certification, available through purchase or service agreement
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Alere Toxicology product offering
Product offeringCore offering
Alere Toxicology (now Abbott Toxicology) provides comprehensive drug and alcohol testing solutions spanning rapid point-of-collection screening devices (such as the iCup urine drug screen cup) and full laboratory toxicology services for urine and oral fluid specimens. It serves workplace, government, and clinical customers with managed screening programs, laboratory confirmation, online result reporting, and a training/certification platform (Learning XChange).
Product overview
Alere Toxicology (now Abbott Toxicology) offers a comprehensive drug and alcohol testing portfolio spanning managed solutions, on-site point-of-collection screening, laboratory testing, and oral fluid testing. The product portfolio includes the iCup™ rapid drug test cup as the flagship screening device, supported by laboratory services (urine and oral fluid testing), reagent products, and rapid screening devices. The company provides integrated result reporting through DATALINK and supports customer training via the Learning XChange platform. Solutions are organized across Workplace Screening, Government, and Clinical Toxicology market segments.
Differentiator
Problem solved
Functional benefit
Brands
- iCup: iCup™ - Our most widely used rapid drug test cup.
Products and services
- iCup Urine Test Drug Screen Cup The company's most widely used rapid drug test cup, providing point-of-collection screening results to enable informed decisions about substance misuse or abuse for workplace, government, and clinical customers.
- Reagents Reagent products supplied for toxicology screening applications, sold as consumables to support ongoing drug testing programs.
- Urine Laboratory Drug Testing Laboratory-based urine drug testing services with 30+ years of experience, supported by multiple dedicated toxicology laboratories worldwide for workplace, government, and clinical customers.
- Oral Fluid Drug Testing Laboratory Laboratory-based oral fluid drug testing services providing an alternative specimen matrix for drug screening customers.
- Online Result Reporting (DATALINK) Online drug screening activity reporting systems providing up-to-the-minute, real-time access to test results for employer, government, and clinical customers.
- Learning XChange Online on-demand training and certification platform that teaches drug screen procedures consistent with manufacturer recommendations, with quizzes and Certificates of Completion.
Companies that use Alere Toxicology
Customer profileSegments3 records
Ideal customer profiles3 records
Alere Toxicology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Alere Toxicology partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Alere Toxicology competitors and assessment
Company assessmentEmerging players
- Omega Laboratories: Specialized toxicology laboratory providing urine, hair, and oral fluid drug testing for workplace, legal, and clinical markets. Competes in similar customer segments with a focus on specialty panels and turnaround time.
- Drägerwerk: Provider of alcohol and drug detection instruments including breathalyzers and point-of-collection testing devices. Competes in the workplace and law enforcement screening market, particularly for alcohol and oral fluid testing.
- Psychemedics Corporation: Specialized toxicology laboratory focused on hair-based drug testing for workplace and school screening. Competes in the broader employer toxicology market with an alternative specimen type that overlaps with Alere Toxicology's urine and oral fluid offerings.
- Lifeloc Technologies: Manufacturer of breath alcohol testing instruments and Evidential Breath Testers used in workplace, law enforcement, and corrections drug and alcohol programs. Adjacent competitor in workplace substance abuse testing, particularly for alcohol.
Direct peers
- Quest Diagnostics: National reference laboratory offering workplace drug testing, forensic toxicology, and employer health screening services. Directly competes with Alere Toxicology's laboratory urine and oral fluid testing across enterprise workplace and government accounts.
- Laboratory Corporation of America (Labcorp): Major US reference laboratory providing employer drug testing, occupational health, and clinical toxicology services. Competes head-to-head with Alere Toxicology for large employer and government testing contracts and has comparable scale in specimen logistics.
- Premier Biotech: Manufacturer of rapid urine drug screening cups and oral fluid devices sold to workplace, government, and clinical customers. Direct product competitor to the iCup rapid screening franchise.
- Clinical Reference Laboratory (CRL): Reference laboratory offering workplace drug testing, clinical diagnostics, and specialty testing services. Directly competes with Alere Toxicology for employer and occupational health accounts, particularly in the mid-market segment.
Regional players
- Randox Toxicology: UK-headquartered toxicology laboratory offering drug and alcohol testing services and reagents across Europe and select international markets. Regional peer with comparable laboratory testing and reagent capabilities but limited US footprint.
Broad incumbents
- Abbott Diagnostics (parent division): Parent company and broader diagnostics division operating clinical chemistry, immunoassay, and point-of-care diagnostics. The toxicology business is housed within Abbott's Point of Care organization, and broader Abbott capabilities provide cross-sell and infrastructure leverage.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Alere Toxicology social profiles
Digital presenceAlere Toxicology compliance and trust
Trust signalCompliance1 record
Alere Toxicology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alere Toxicology leadership team
Management profileNumber of profiles
Alere Toxicology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alere Toxicology M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alere Toxicology
What does Alere Toxicology do?
Alere Toxicology (now Abbott Toxicology) provides comprehensive drug and alcohol testing solutions spanning rapid point-of-collection screening devices (such as the iCup urine drug screen cup) and full laboratory toxicology services for urine and oral fluid specimens. It serves workplace, government, and clinical customers with managed screening programs, laboratory confirmation, online result reporting, and a training/certification platform (Learning XChange).
Is Alere Toxicology a public or private company?
Alere Toxicology is a private company. It is classified as corporate owned and is currently operating.
When was Alere Toxicology founded?
Alere Toxicology was founded in 1987. It employs 5,001 to 10,000 people.
Where is Alere Toxicology based?
Alere Toxicology is headquartered in Richmond, United States, in the North America region.
How does Alere Toxicology make money?
Four revenue lines are on record. Laboratory Testing Services are the primary driver. The others are rapid Screening Products, reagents and Consumables and training Services.
Who are Alere Toxicology's main competitors?
Emerging players on record are Omega Laboratories, Drägerwerk, Psychemedics Corporation and Lifeloc Technologies. Direct peers are Quest Diagnostics, Laboratory Corporation of America (Labcorp), Premier Biotech and Clinical Reference Laboratory (CRL). Randox Toxicology is listed as a regional player. Abbott Diagnostics (parent division) is listed as a broad incumbent.
Does Alere Toxicology have an API?
No public API is recorded for Alere Toxicology.
What industry is Alere Toxicology in?
Alere Toxicology's product category is Drug and Alcohol Testing Services. Its primary akta.pro industry code is HLAHAOAG, Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels). Its NAICS code is 62151 and its SIC code is 8071.